Nicotinamide overload may play a role in the development of type 2 diabetes

World Journal of Gastroenterology

Volumn 15, Issue 45, 2009, Pages 5674-5684

  Zhou, Shi Sheng ^a   Li, Da ^a   Sun, Wu Ping ^a   Guo, Ming ^a   Lun, Yong Zhi ^a   Zhou, Yi Ming ^b   Xiao, Fu Cheng ^a   Jing, Li Xin ^a   Sun, Shen Xia ^a   Zhang, Li Bin ^c   Luo, Ning ^a   Bian, Fu Ning ^a   Zou, Wei ^d   Dong, Lai Bin ^e   Zhao, Zhi Gang ^f   Li, Sheng Fan ^a   Gong, Xiao Jie ^a   Yu, Zeng Guo ^a   Sun, Chang Bin ^a   Zheng, Cong Long ^a   Jiang, Dong Ju ^f   Li, Zheng Ning ^a   more..

^a DALIAN UNIVERSITY   (China)

^b OKAZAKI INSTITUTE FOR INTEGRATIVE BIOSCIENCE   (Japan)

^c XINXIANG MEDICAL UNIVERSITY   (China)

^d LIAONING NORMAL UNIVERSITY   (China)

^e PLA No 91 Central Hospital   (China)

^f The 210th Hospital of PLA   (China)

Author keywords

Insulin resistance; Liver; Nicotinamide; Oxidative stress; Sweat glands; Type 2 diabetes

Indexed keywords

1 METHYLNICOTINAMIDE; ALDEHYDE OXIDASE; GLUCOSE; INSULIN; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; OLANZAPINE; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CONTROLLED STUDY; DETOXIFICATION; ENZYME INHIBITION; ERYTHROCYTE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; RAT; SAUNA; SKIN DEFECT; SWEATING; VITAMIN METABOLISM;

EID: 74049120204     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.5674     Document Type: Article

References (46)

1. Meigs JB, Larson MG, Fox CS, Keaney JF Jr, Vasan RS, Benjamin EJ. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care 2007; 30: 2529-2535
2. Paravicini TM, Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 2008; 31 Suppl 2: S170-S180
3. Andreassi MG. Metabolic syndrome, diabetes and atherosclerosis: influence of gene-environment interaction. Mutat Res 2009; 667: 35-43
4. Booth FW, Gordon SE, Carlson CJ, Hamilton MT. Waging war on modern chronic diseases: primary prevention through exercise biology. J Appl Physiol 2000; 88: 774-787
5. Roche HM, Phillips C, Gibney MJ. The metabolic syndrome: the crossroads of diet and genetics. Proc Nutr Soc 2005; 64: 371-377
6. Li F, Chong ZZ, Maiese K. Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide. Curr Med Chem 2006; 13: 883-895
7. Kitamura S, Nitta K, Tayama Y, Tanoue C, Sugihara K, Inoue T, Horie T, Ohta S. Aldehyde oxidase-catalyzed metabolism of N1-methylnicotinamide in vivo and in vitro in chimeric mice with humanized liver. Drug Metab Dispos 2008; 36: 1202-1205
8. Knip M, Douek IF, Moore WP, Gillmor HA, McLean AE, Bingley PJ, Gale EA. Safety of high-dose nicotinamide: a review. Diabetologia 2000; 43: 1337-1345
9. Williams A, Ramsden D. Nicotinamide: a double edged sword. Parkinsonism Relat Disord 2005; 11: 413-420
10. Chang AM, Smith MJ, Galecki AT, Bloem CJ, Halter JB. Impaired beta-cell function in human aging: response to nicotinic acid-induced insulin resistance. J Clin Endocrinol Metab 2006; 91: 3303-3309
11. Greenbaum CJ, Kahn SE, Palmer JP. Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM. Diabetes 1996; 45: 1631-1634
12. Kahn SE, Beard JC, Schwartz MW, Ward WK, Ding HL, Bergman RN, Taborsky GJ Jr, Porte D Jr. Increased beta-cell secretory capacity as mechanism for islet adaptation to nicotinic acid-induced insulin resistance. Diabetes 1989; 38: 562-568
13. Gross LS, Li L, Ford ES, Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 2004; 79: 774-779
14. Backstrand JR. The history and future of food fortification in the United States: a public health perspective. Nutr Rev 2002; 60: 15-26
15. Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, Mo J, Whelton PK, He J. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003; 46: 1190-1198
16. Hirayama T, Yoshida K, Uda K, Nohara M, Fukui S. High-performance liquid chromatographic determination of N1-alkylnicotinamide in urine. Anal Biochem 1985; 147: 108-113
17. Holman WI, Wiegand C. The chemical conversion of nicotinic acid and nicotinamide to derivatives of N-methyl-2-pyridone by methylation and oxidation. Biochem J 1948; 43: 423-426
18. Kasper SO, Castle SM, Daley BJ, Enderson BL, Karlstad MD. Blockade of the renin-angiotensin system improves insulin sensitivity in thermal injury. Shock 2006; 26: 485-488
19. Musfeld C, Biollaz J, Bélaz N, Kesselring UW, Decosterd LA. Validation of an HPLC method for the determination of urinary and plasma levels of N1-methylnicotinamide, an endogenous marker of renal cationic transport and plasma flow. J Pharm Biomed Anal 2001; 24: 391-404
20. Clark BR. Fluorometric quantitation of picomole amounts of 1-methylnicotinamide and nicotinamide in serum. Methods Enzymol 1980; 66: 5-8
21. Ido Y. Pyridine nucleotide redox abnormalities in diabetes. Antioxid Redox Signal 2007; 9: 931-942
22. Garattini E, Fratelli M, Terao M. Mammalian aldehyde oxidases: genetics, evolution and biochemistry. Cell Mol Life Sci 2008; 65: 1019-1048
23. Obach RS, Huynh P, Allen MC, Beedham C. Human liver aldehyde oxidase: inhibition by 239 drugs. J Clin Pharmacol 2004; 44: 7-19
24. Ahmed MH, Osman KA. Tamoxifen induced-non-alcoholic steatohepatitis (NASH): has the time come for the oncologist to be diabetologist. Breast Cancer Res Treat 2006; 97: 223-224
25. Newcomer JW. Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 2007; 68 Suppl 4: 8-13
26. Moriwaki Y, Yamamoto T, Yamaguchi K, Takahashi S, Higashino K. Immunohistochemical localization of aldehyde and xanthine oxidase in rat tissues using polyclonal antibodies. Histochem Cell Biol 1996; 105: 71-79
27. Ueda O, Sugihara K, Ohta S, Kitamura S. Involvement of molybdenum hydroxylases in reductive metabolism of nitro polycyclic aromatic hydrocarbons in mammalian skin. Drug Metab Dispos 2005; 33: 1312-1318
28. Vankhanen VD, Shaptala AA, Zaǐtseva TA, Shaptala VA. [Elimination of water-soluble vitamins with the sweat and their body allowance in miners working at deep levels] Gig Tr Prof Zabol 1973; 17: 46-48
29. Beyer KH, Russo HF. Renal tubular elimination of N1-methylnicotinamide. Am J Physiol 1950; 160: 311-320
30. Krützfeldt J, Kausch C, Volk A, Klein HH, Rett K, Häring HU, Stumvoll M. Insulin signaling and action in cultured skeletal muscle cells from lean healthy humans with high and low insulin sensitivity. Diabetes 2000; 49: 992-998
31. Turinsky J, Saba TM, Scovill WA, Chesnut T. Dynamics of insulin secretion and resistance after burns. J Trauma 1977; 17: 344-350
32. Zierath JR, Galuska D, Nolte LA, Thörne A, Kristensen JS, Wallberg-Henriksson H. Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance. Diabetologia 1994; 37: 270-277
33. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944-948
34. Ying W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 2008; 10: 179-206
35. Strosznajder RP, Jesko H, Zambrzycka A. Poly(ADP-ribose) polymerase: the nuclear target in signal transduction and its role in brain ischemia-reperfusion injury. Mol Neurobiol 2005; 31: 149-167
36. Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, Maldonado-Garza H. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 2009; 15: 280-288
37. Watanabe S, Yaginuma R, Ikejima K, Miyazaki A. Liver diseases and metabolic syndrome. J Gastroenterol 2008; 43: 509-518
38. Pumpo R, Sarnelli G, Spinella A, Budillon G, Cuomo R. The metabolism of nicotinamide in human liver cirrhosis: a study on N-methylnicotinamide and 2-pyridone-5-carboxamide production. Am J Gastroenterol 2001; 96: 1183-1187
39. Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ 3rd, Jeschke MG. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab 2009; 94: 1656-1664
40. van Dam RM, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med 2002; 136: 201-209
41. Heidemann C, Hoffmann K, Spranger J, Klipstein-Grobusch K, Möhlig M, Pfeiffer AF, Boeing H. A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC) - Potsdam Study cohort. Diabetologia 2005; 48: 1126-1134
42. Doró P, Benko R, Matuz M, Soós G. Seasonality in the incidence of type 2 diabetes: a population-based study. Diabetes Care 2006; 29: 173
43. Liang WW. Seasonal changes in preprandial glucose, A1C, and blood pressure in diabetic patients. Diabetes Care 2007; 30: 2501-2502
44. Manson JE, Nathan DM, Krolewski AS, Stampfer MJ, Willett WC, Hennekens CH. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992; 268: 63-67
45. Bhardwaj SS, Chalasani N. Lipid-lowering agents that cause drug-induced hepatotoxicity. Clin Liver Dis 2007; 11: 597-613, vii
46. Jaus H, Sturm G, Grässle B, Romen W, Siebert G. Metabolic effects and liver damage after prolonged administration of high doses of nicotinamide to rats. Nutr Metab 1977; 21 Suppl 1: 38-41